IKNA (ikenaoncology.com) Company Cash Funds

Corporate company logo of Ikena Oncology (IKNA)

Ikena Oncology, Inc. (IKNA) relies on streamlined component supplies for drug development. The cash level on the GURU.Markets dynamic chart demonstrates liquidity, where the value 0.10 indicates the parameter's status. The development of targeted therapies for hospitals provides access to a massive market. The brand's high authority in the field of rare genetic mutations confirms the company's expertise in precision medicine.

Company Cash and Cash Equivalents: Ikena Oncology, Inc. (IKNA) for 07/04/2022 - 08/09/2025

Summary analytical data breakdowns for ikenaoncology.com (IKNA)

- current price and projected stock value:
- cash and cash flow metrics:
General company analysis:IKNA Ikena Oncology
Signature product of Ikena Oncology, Inc.

This metric measures the total volume of liquid assets, determining the business's ability to operate without external financing. Growing reserves minimize default risk, whereas stagnation signals inefficient capital utilization. By analyzing the volume of highly liquid cash, an investor assesses the company's margin of safety during periods of turbulence. For Ikena Oncology, Inc. (IKNA), this is critical for supporting the costly logistics of clinical trials. Sufficient liquidity guarantees the uninterrupted delivery of biomaterials through international channels.

Competitors of Ikena Oncology, Inc. (IKNA)

Company Cash Volume ONC|HALO - Company Cash Reserve|Revolution Medicines - Company Cash on Hand|Company Cash Volume Ascentage Pharma AAPG|CGON - Company Cash Funds|Company Total Cash Volume URGN|BCAX: Company Cash Volume|PSNL - Company Liquid Assets|ERAS (Erasca Inc) - Company Cash Volume|Company Cash Reserve Delcath Systems Inc DCTH|Company Cash Funds YmAbs (YMAB)|Company Liquid Assets Aura Bio|Company Cash Volume CADL (Candel Therapeutics Inc.)|accuray.com (ARAY) - Company Cash Reserve|SELLAS Life Sciences Group - Company Cash Volume|ACTU - Company Cash Volume|CTOR: Company Cash Volume|Company Cash Reserve TuHURA (HURA)|TARA (Protara Therapeutics Inc) - Company Cash Volume|Fate Therapeutics, Inc. (FATE) - Company Liquid Assets|Company Cash on Hand WHWK (Aadi Bioscience, Inc.)|Company Liquid Assets TScan Therapeutics, Inc.|Company Cash Volume CSBR (Champions Oncology Corp)|Company Total Cash Amount XBIT (XBiotech USA)|CVM - Company Cash Funds|Company Cash Balance OSTX (ostherapies.com)|Radiopharm Theranostics Ltd (RADX) - Company Cash Funds|ARTV: Company Total Cash Amount|ANL (adlainortye.com) - Company Cash Volume|VERU: Company Cash Balance|Company Cash on Hand TPST (Tempest Tx)|Company Cash on Hand Xilio XLO|Company Cash Volume RENB (Renovaro)|Company Cash Volume Mural Bio MURA|Kairos Pharma Ltd - Company Cash Volume|OnKure Therapeutics (OKUR) - Company Cash on Hand|GDTC: Company Cash Volume|Curis Inc. - Company Cash Balance|Company Cash Funds apollomicsinc.com|THAR: Company Cash Balance|Company Cash Funds Advanced Biomed Corp (ADVB)|GNPX (Genprex, Inc) - Company Cash Balance|Company Cash Volume CLDI (Calidi Biotherapeutics)|sunshinebiopharma.com (SBFM) - Company Cash Reserve|Xenetic Bio - Company Cash Volume|SLRX (Salarius Pharmaceuticals, Inc.) - Company Cash and Cash Equivalents|PPBT: Company Cash Volume|Company Cash on Hand American Oncology Network Inc|BGNE (beigene.com) - Company Cash Volume|Company Cash and Cash Equivalents CKPT (Checkpoint Therapeutics)|Company Cash on Hand ELEV (Elevation Oncology Inc.)|iCAD - Company Cash and Cash Equivalents|Company Cash Volume NTBL (notablelabs.com)|VIRX - Company Cash on Hand|MOR: Company Cash on Hand|NAYA - Company Cash Volume|Ascentage Pharma (AAPGV) - Company Cash Funds